Normal delivery following an uneventful pregnancy in a Japanese acromegalic patient after discontinuation of octreotide long acting release formulation at an early phase of pregnancy

Endocrine Journal

Volumn 53, Issue 2, 2006, Pages 209-212

  Takano, Tatsuro ^a   Saito, Jun ^a   Soyama, Akiko ^a   Ito, Hiroko ^a   Iizuka, Takashi ^a   Yoshida, Takao ^b   Nishikawa, Tetsuo ^a  

^a YOKOHAMA ROSAI HOSPITAL   (Japan)

^b Department of Obstetrics and Gynecology   (Japan)

Author keywords

Acromegaly; Delivery; Octreotide LAR; Pregnancy

Indexed keywords

BROMOCRIPTINE; OCTREOTIDE;

ABSENCE OF SIDE EFFECTS; ACROMEGALY; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DRUG RELEASE; DRUG SAFETY; DRUG WITHDRAWAL; ENDOCRINE SURGERY; FEASIBILITY STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GAMMA KNIFE RADIOSURGERY; GROWTH HORMONE RELEASE; GYNECOLOGIC DISEASE; HEADACHE; HUMAN; HYPOPHYSIS ADENOMA; IMPAIRED GLUCOSE TOLERANCE; IRRADIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PLACENTAL TRANSFER; POSTNATAL DEVELOPMENT; PREGNANCY; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VAGINAL DELIVERY;

ACROMEGALY; ADULT; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; JAPAN; OCTREOTIDE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; TIME; WITHHOLDING TREATMENT;

EID: 33645846939     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.53.209     Document Type: Article

References (21)

1. Chaudhry A, Kvols L (1996) Advances in the use of somatostatins in the management of endocrine tumors. Curr Opin Oncol 8: 44-48.
2. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ (1996) Somatostatin analogs: future directions. Metabolism 45 (Suppl 1): 104-106.
3. Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK (1998) Carcinoid tumour. Lancet 352: 799-805.
4. McDermott MT, Ridgway EC (1998) Central hyperthyroidism. Endocrinol Metab Clin North Am 27: 187-203.
5. Stewart PM, Kane KF, Stewart SE, Lancranjan I, Sheppard MC (1995) Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly. J Clin Endocrinol Metab 80: 3267-3272.
6. Lancranjan I, Bruns C, Grass P, Jaquet P, Jervell J, Kendall-Taylor P, Lambers SW, Marbach P, Orskov H, Pagani G, Sheppard M, Simionescu L (1996) Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients. Metabolism 45 (Suppl 1): 67-71.
7. Newman CB (1999) Medical therapy for acromegaly. Endocrinol Metab Clin North Am 28: 171-190.
8. Herman-Bonert V, Seliverstov M, Melmed S (1998) Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 83: 727-731.
9. Molitch ME (1998) Pituitary diseases in pregnancy. Semin Perinatol 22: 457-470.
10. Serri O, Lanoie G (2003) Successful pregnancy in a woman with acromegaly treated with Octreotide Long-acting Release. Endocrinologist 13: 17-19.
11. Fassnacht M, Capeller B, Arlt W, Steck T, Allolio B (2001) Octreotide LAR® treatment throughout pregnancy in an acromegalic woman. Clin Endocrinol (Oxf) 55: 411-415.
12. Colao A, Merola B, Ferone D, Lombardi G (1997) Acromegaly. J Clin Endocrinol Metab 82: 2777-2781.
13. Yoshimatsu J, Eto Y, Ohgami M, Anai T, Gholbzouri K, Miyagawa Y (1994) A case of pregnancy concomitant with acromegaly treated with octreotide acetate. Acta Obste Gynecol Jap 46: S420.
14. Hierl T, Ziegler R, Kasperk C (2000) Pregnancy in persistent acromegaly. Clin Endocrinol (Oxf) 53: 262-263.
15. Neal JM (2000) Successful pregnancy in a woman with acromegaly treated with octreotide. Endocr Pract 6: 148-150.
16. Shimazu A, Usui K, Tagami T, Kuzuya H (2001) The dynamics of the GH-IGF-1 system in acromegaly during pregnancy and after delivery. Folia Endocrinol Jap 6: 148-150 (in Japanese).
17. Mikhail N (2002) Octreotide treatment of acromegaly during pregnancy. Mayo Clin Proc 77: 297-298.
18. Caron P, Gerbeau C (1995) Pradayrol L. Maternal-fetal transfer of octreotide. N Engl J Med 333: 601-602.
19. Caron P, Buscail L, Beckers A, Esteve JP, Hennen G, Susini C (1997) Suppression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J Clin Endocrinol Metab 82: 3771-3776.
20. Beckers A, Stevenaert A, Foidert JM, Hennen G, Frankenne F (1990) Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab 71: 725-731.
21. Okada Y, Morimoto I, Ejima K, Yoshida K, Kashimura M, Fujihara T, Eto S (1997) A case of acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery. Endocr J 44: 117-120.